The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Difloxacine     6-fluoro-1-(4-fluorophenyl)- 4-oxo-7...

Synonyms: Difloxacino, Difloxacinum, Sarafloxacin, Sarafloxacine, Sarafloxacino, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of HSDB 7035


High impact information on HSDB 7035


Chemical compound and disease context of HSDB 7035


Biological context of HSDB 7035


Anatomical context of HSDB 7035


Associations of HSDB 7035 with other chemical compounds


Analytical, diagnostic and therapeutic context of HSDB 7035


  1. In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones. Fernandes, P.B., Chu, D.T., Bower, R.R., Jarvis, K.P., Ramer, N.R., Shipkowitz, N. Antimicrob. Agents Chemother. (1986) [Pubmed]
  2. In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620. Eliopoulos, G.M., Moellering, A.E., Reiszner, E., Moellering, R.C. Antimicrob. Agents Chemother. (1985) [Pubmed]
  3. Activity of difloxacin (A-56619) and A-56620 against clinical anaerobic bacteria in vitro. Bansal, M.B., Thadepalli, H. Antimicrob. Agents Chemother. (1987) [Pubmed]
  4. In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones. Stamm, J.M., Hanson, C.W., Chu, D.T., Bailer, R., Vojtko, C., Fernandes, P.B. Antimicrob. Agents Chemother. (1986) [Pubmed]
  5. Therapeutic evaluation of difloxacin (A-56619) and A-56620 for experimentally induced Bacteroides fragilis-associated intra-abdominal abscess. Thadepalli, H., Gollapudi, S.V., Chuah, S.K. Antimicrob. Agents Chemother. (1986) [Pubmed]
  6. Ciprofloxacin resistance in Campylobacter jejuni evolves rapidly in chickens treated with fluoroquinolones. McDermott, P.F., Bodeis, S.M., English, L.L., White, D.G., Walker, R.D., Zhao, S., Simjee, S., Wagner, D.D. J. Infect. Dis. (2002) [Pubmed]
  7. Separation and quantification of two fluoroquinolones in serum by on-line high-performance immunoaffinity chromatography. Holtzapple, C.K., Pishko, E.J., Stanker, L.H. Anal. Chem. (2000) [Pubmed]
  8. In vitro activities of tosufloxacin, temafloxacin, and A-56620 against pathogens of diarrhea. Bryan, J.P., Waters, C., Sheffield, J., Krieg, R.E., Perine, P.L., Wagner, K. Antimicrob. Agents Chemother. (1990) [Pubmed]
  9. In vitro comparison of A-56619, A-56620, amifloxacin, ciprofloxacin, enoxacin, norfloxacin, and ofloxacin against methicillin-resistant Staphylococcus aureus. Smith, S.M. Antimicrob. Agents Chemother. (1986) [Pubmed]
  10. In vitro evaluation of A-56619 and A-56620, two new quinolones. Barry, A.L., Thornsberry, C., Jones, R.N. Antimicrob. Agents Chemother. (1986) [Pubmed]
  11. Effects of sarafloxacin hydrochloride on human enteric bacteria under simulated human gut conditions. McConville, M.L., Dijkstra, J.W., Stamm, J.M., van Saene, J.J., Nouws, J.F. The Veterinary quarterly. (1995) [Pubmed]
  12. Aryl-fluoroquinolone derivatives A-56619 (difloxacin) and A-56620 inhibit mitogen-induced human mononuclear cell proliferation. Gollapudi, S.V., Vayuvegula, B., Gupta, S., Fok, M., Thadepalli, H. Antimicrob. Agents Chemother. (1986) [Pubmed]
  13. Kinetic modelling of the intestinal transport of sarafloxacin. Studies in situ in rat and in vitro in Caco-2 cells. Fernandez-Teruel, C., Gonzalez-Alvarez, I., Casabó, V.G., Ruiz-Garcia, A., Bermejo, M. Journal of drug targeting. (2005) [Pubmed]
  14. Pharmacokinetics of sarafloxacin in pigs and broilers following intravenous, intramuscular, and oral single-dose applications. Ding, H.Z., Zeng, Z.L., Fung, K.F., Chen, Z.L., Qiao, G.L. J. Vet. Pharmacol. Ther. (2001) [Pubmed]
  15. Metabolism of the veterinary fluoroquinolone sarafloxacin by the fungus Mucor ramannianus. Parshikov, I.A., Freeman, J.P., Lay, J.O., Moody, J.D., Williams, A.J., Beger, R.D., Sutherland, J.B. J. Ind. Microbiol. Biotechnol. (2001) [Pubmed]
  16. Determination of total 14C residues of sarafloxacin in eggs of laying hens. Chu, P.S., Donoghue, D.J., Shaikh, B. J. Agric. Food Chem. (2000) [Pubmed]
  17. The comparative in-vitro activity of eight newer quinolones and nalidixic acid. King, A., Phillips, I. J. Antimicrob. Chemother. (1986) [Pubmed]
  18. Development of a new sample pretreatment procedure based on pressurized liquid extraction for the determination of fluoroquinolone residues in table eggs. Herranz, S., Moreno-Bondi, M.C., Marazuela, M.D. Journal of chromatography. A (2007) [Pubmed]
  19. Confirmatory and quantitative analysis using experimental design for the extraction and liquid chromatography-UV, liquid chromatography-mass spectrometry and liquid chromatography-mass spectrometry/mass spectrometry determination of quinolones in turkey muscle. Clemente, M., Hermo, M.P., Barr??n, D., Barbosa, J. Journal of chromatography. A (2006) [Pubmed]
  20. Determination of temafloxacin, sarafloxacin, and difloxacin in bulk drug and dosage forms by high-performance liquid chromatography. Bauer, J.F., Elrod, L., Fornnarino, J.R., Heathcote, D.E., Krogh, S.K., Linton, C.L., Norris, B.J., Quick, J.E. Pharm. Res. (1990) [Pubmed]
  21. In vitro susceptibility of avian mycoplasmas to enrofloxacin, sarafloxacin, tylosin, and oxytetracycline. Wang, C., Ewing, M., Aarabi, S.Y. Avian Dis. (2001) [Pubmed]
  22. Determination of sarafloxacin residues in fortified and incurred eggs using on-line microdialysis and HPLC/programmable fluorescence detection. Maxwell, R.J., Cohen, E., Donoghue, D.J. J. Agric. Food Chem. (1999) [Pubmed]
  23. The use of near-infrared spectroscopy to monitor the mobility of water within the sarafloxacin crystal lattice. Dziki, W., Bauer, J.F., Szpylman, J.J., Quick, J.E., Nichols, B.C. Journal of pharmaceutical and biomedical analysis. (2000) [Pubmed]
  24. Determination of difloxacin and sarafloxacin in chicken muscle using solid-phase extraction and capillary electrophoresis. Barrón, D., Jiménez-Lozano, E., Bailac, S., Barbosa, J. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. (2002) [Pubmed]
  25. Pharmacokinetic and depletion studies of sarafloxacin after oral administration to eel (Anguilla anguilla). Ho, S.P., Cheng, C.F., Wang, W.S. J. Vet. Med. Sci. (1999) [Pubmed]
WikiGenes - Universities